The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature Infants
Condition(s) studied
Study summary
The aim of this observational study is to investigate whether functional maturation assessment by electroencephalography in preterm infants can provide reliable data for the safe discontinuation of caffeine therapy without recurrence of apnea.
In preterm infants receiving caffeine therapy, an assessment of maturation will be performed by EEG at the time when discontinuation of caffeine treatment is planned.
Eligibility
Primary outcome measure(s)
- Assessment of apnea risk after discontinuation of caffeine therapy in preterm infants. — From enrollment to the end of treatment at 4 weeks
Apnea of prematurity is defined as a sudden cessation of breathing lasting at least 20 seconds, or of shorter duration if accompanied by bradycardia, cyanosis, pallor, or marked hypotonia.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Division of Neonatology, Department of Pediatrics, Bursa Uludağ University Faculty of Medicine | Bursa | Turkey (Türkiye) | Recruiting |
More Uludag University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07324941 on ClinicalTrials.gov ↗ ← All trials in Turkey